March 1, 2011
Use of a Genomic Test (MammaPrint™) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients
Arch Gynecol Obstet (2011) 283: 597. https://doi.org/10.1007/s00404-010-1454-9.
44 patients had MammaPrint results and were eligible for the analysis. The results revealed a low risk result in 29 patients and a high risk result in 15 patients.